These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 27787906

  • 21. Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis.
    Mellergård J, Tisell A, Blystad I, Grönqvist A, Blennow K, Olsson B, Dahle C, Vrethem M, Lundberg P, Ernerudh J.
    Eur J Neurol; 2017 Jan; 24(1):112-121. PubMed ID: 27699930
    [Abstract] [Full Text] [Related]

  • 22. A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course.
    Huss A, Otto M, Senel M, Ludolph AC, Abdelhak A, Tumani H.
    Front Neurol; 2020 Jan; 11():608. PubMed ID: 32765393
    [Abstract] [Full Text] [Related]

  • 23. Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.
    Axelsson M, Malmeström C, Nilsson S, Haghighi S, Rosengren L, Lycke J.
    J Neurol; 2011 May; 258(5):882-8. PubMed ID: 21197541
    [Abstract] [Full Text] [Related]

  • 24. Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.
    Gil-Perotin S, Castillo-Villalba J, Cubas-Nuñez L, Gasque R, Hervas D, Gomez-Mateu J, Alcala C, Perez-Miralles F, Gascon F, Dominguez JA, Casanova B.
    Front Neurol; 2019 May; 10():1008. PubMed ID: 31608004
    [Abstract] [Full Text] [Related]

  • 25. Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.
    de Flon P, Laurell K, Sundström P, Blennow K, Söderström L, Zetterberg H, Gunnarsson M, Svenningsson A.
    Acta Neurol Scand; 2019 May; 139(5):462-468. PubMed ID: 30740668
    [Abstract] [Full Text] [Related]

  • 26. Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
    Martínez MA, Olsson B, Bau L, Matas E, Cobo Calvo Á, Andreasson U, Blennow K, Romero-Pinel L, Martínez-Yélamos S, Zetterberg H.
    Mult Scler; 2015 Apr; 21(5):550-61. PubMed ID: 25732842
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. CSF chitinase proteins in amyotrophic lateral sclerosis.
    Thompson AG, Gray E, Bampton A, Raciborska D, Talbot K, Turner MR.
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1215-1220. PubMed ID: 31123140
    [Abstract] [Full Text] [Related]

  • 30. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R, Krýsl D, Bergquist F, Andrén K, Malmeström C, Asztély F, Axelsson M, Menachem EB, Blennow K, Rosengren L, Zetterberg H.
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.
    Wessels MH, Van Lierop ZY, Noteboom S, Strijbis EM, Heijst JA, Van Kempen ZL, Moraal B, Barkhof F, Uitdehaag BM, Schoonheim MM, Killestein J, Teunissen CE.
    Mult Scler; 2023 Sep; 29(10):1229-1239. PubMed ID: 37530045
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
    Koerbel K, Maiworm M, Schaller-Paule M, Schäfer JH, Jakob J, Friedauer L, Steffen F, Bittner S, Foerch C, Yalachkov Y.
    Mult Scler Relat Disord; 2024 Jul; 87():105644. PubMed ID: 38701697
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Multiple sclerosis: Biomarkers and genetic variants reflect disease course in multiple sclerosis.
    Wood H.
    Nat Rev Neurol; 2016 Oct; 12(10):553. PubMed ID: 27615421
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.